| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
As a synthetic dye, C.I. Acid Orange 7 does not have a specific pharmacological target. Its primary applications are industrial, particularly in textile dyeing and printing. The compound may interact with biological systems through non-specific mechanisms, and its azo bond can be reduced to aromatic amines. Further research is needed to identify any specific molecular targets.
|
|---|---|
| ln Vitro |
C.I. Acid Orange 7 itself is not known to possess direct therapeutic activity. Its significance is as a synthetic dye for industrial applications. The compound is used in textile dyeing, printing, and as a colorant. As an azo dye, it may undergo metabolic reduction to aromatic amines, which could have biological effects, but these are not considered therapeutic.
|
| ln Vivo |
There is no reported in vivo therapeutic activity for C.I. Acid Orange 7, as it is primarily an industrial colorant rather than a drug candidate. The compound is used in textile dyeing and printing applications. Its role in biological systems is primarily as a coloring agent rather than a pharmacologically active compound.
|
| Enzyme Assay |
As a synthetic dye, there are no standardized in vitro enzyme/receptor binding assays for C.I. Acid Orange 7 itself. The compound's utility is in industrial applications such as textile dyeing and printing. Researchers may study the compound's interactions with biological systems in the context of dye metabolism or toxicity.
|
| Cell Assay |
There are no reported in vitro cellular assays for C.I. Acid Orange 7 as a therapeutic agent. The compound is used in industrial applications. Cellular studies may be conducted to assess the compound's toxicity, metabolism, or potential for causing skin or eye irritation, but these are not therapeutic assays.
|
| Animal Protocol |
There are no reported in vivo animal studies for C.I. Acid Orange 7 as a therapeutic agent. The compound is primarily used in industrial applications. Animal studies may be conducted to assess the compound's toxicity, metabolism, or potential for causing skin or eye irritation, but these are not therapeutic studies.
|
| ADME/Pharmacokinetics |
As a synthetic dye used in industrial applications, there are limited pharmacokinetic data for C.I. Acid Orange 7. The compound has a molecular weight of 350.33 and is soluble in water and alcohols. It may be absorbed through skin or ingestion. The compound has a melting point of 164°C and a density of 1.53 g/cm³.
|
| Toxicity/Toxicokinetics |
The toxicological properties of C.I. Acid Orange 7 have not been fully investigated. May cause irritation of the digestive tract, respiratory tract, and skin. According to GHS classification, Acid Orange 7 has skin irritation (Category 2) and eye irritation (Category 2A) risks. Prolonged exposure may cause serious damage to health. The compound should be handled with appropriate safety precautions.
|
| References | |
| Additional Infomation |
Acid Orange 7 belongs to the naphthalene family of compounds.
See also: Orange (note moved to). C.I. Acid Orange 7 (Orange II, β-Naphthol Orange) is a synthetic azo dye used in textile dyeing, printing, and as a colorant in various industrial applications. It is an orange crystalline powder with a molecular weight of 350.32. The compound has skin irritation (Category 2) and eye irritation (Category 2A) risks according to GHS classification. It is not a therapeutic agent but an industrial colorant. |
| Molecular Formula |
C16H11N2NAO4S
|
|---|---|
| Molecular Weight |
350.32
|
| Exact Mass |
350.033
|
| CAS # |
633-96-5
|
| PubChem CID |
135442941
|
| Appearance |
Orange to red solid powder
|
| Melting Point |
164°C
|
| LogP |
4.945
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
24
|
| Complexity |
529
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
CQPFMGBJSMSXLP-UHFFFAOYSA-M
|
| InChi Code |
InChI=1S/C16H12N2O4S.Na/c19-15-10-5-11-3-1-2-4-14(11)16(15)18-17-12-6-8-13(9-7-12)23(20,21)22;/h1-10,19H,(H,20,21,22);/q;+1/p-1
|
| Chemical Name |
sodium;4-[(2-hydroxynaphthalen-1-yl)diazenyl]benzenesulfonate
|
| Synonyms |
NSC-9853; NSC 9853; C.I. Acid Orange 7
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~25 mg/mL (~71.36 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 5 mg/mL (14.27 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication (<60°C).
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8545 mL | 14.2727 mL | 28.5453 mL | |
| 5 mM | 0.5709 mL | 2.8545 mL | 5.7091 mL | |
| 10 mM | 0.2855 mL | 1.4273 mL | 2.8545 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
